Over 40 million people worldwide turn to ChatGPT daily for health information, using the AI to decode medical bills, self-diagnose conditions, and navigate healthcare challenges, despite ongoing safety concerns and lawsuits over potentially dangerous medical advice.
Millions worldwide turn to AI chatbots for therapy amid a global mental health crisis affecting over a billion people, but experts remain divided as some users find relief while others face dangerous outcomes including alleged chatbot-related suicides, raising concerns about privacy and human judgment deterioration.
OpenEvidence secures $210M Series B funding at $3.5B valuation as its medical AI platform now serves over 40% of U.S. physicians daily across 10,000+ hospitals, handling 8.5 million clinical consultations monthly while launching DeepConsult™, the first AI agent designed specifically for autonomous medical research.
AbleMouse launches open-source computer control system offering affordable alternatives to expensive assistive technologies, providing tongue, touch, AI vision, and gesture controls for users with ALS, cerebral palsy, and spinal cord injuries across multiple operating systems.
Scientists successfully simulate an entire mouse brain with 10 million digital neurons on Japan's Fugaku supercomputer, creating a breakthrough that could unlock consciousness mysteries and revolutionize brain disease research including Alzheimer's and epilepsy studies.
Revolutionary AI tool BMVision slashes kidney cancer detection time by up to 52% while boosting diagnostic accuracy by over 6%, enabling radiologists to catch suspicious lesions earlier during routine CT scans and potentially save more lives through faster, more precise diagnosis.
Representative Ocasio-Cortez accuses Trump and Republicans of corruption for pushing a 10-year AI regulation ban while lawmakers allegedly buy AI stocks, as health expert Dr. Havers warns unregulated AI could trigger pandemics and spread dangerous misinformation amid $100 million industry lobbying blitz.
Microsoft releases GigaTIME, an AI tool that generates detailed immune system data from cancer pathology slides in minutes rather than days, potentially revolutionizing precision cancer medicine by eliminating expensive testing that costs thousands of dollars per sample.
Google unveils Gemini 3 Pro, a breakthrough multimodal AI model that delivers state-of-the-art visual reasoning capabilities including complex document processing, pixel-precise spatial understanding, computer screen automation, and high-speed video analysis at 10+ FPS, promising major advances in education, medical imaging, and legal applications.
The European Union announces a massive €20 billion investment to construct five AI gigafactories across Europe, each housing 100,000 advanced AI chips to train complex models for medicine, cleantech, and space applications in a bold bid for technological independence from global competitors.